Last Price Today's Change   Day's Range   Trading Volume
0.93   +0.03 (3.33%)  0.90 - 0.93  979,200
Analyze this stock with MQ Trader system

Insider - Director

Hints :
[1] Click the View Detail icon table to view the detail page.

Click here to modify the Visible Columns.

Ann. Date Name Details of Changes Securities After Change View
Date Type No. of Shares Price Direct (%) Indirect (%) Total (%)
18-Oct-2019 DR MUNAVVAR ZUBAID BIN ABDUL SATTAR 16-Oct-2019 Acquired 350,000 - 0.09 0.11 0.20 View Detail
18-Oct-2019 DR ABDUL MANAF BIN MOHAMAD RADZI 16-Oct-2019 Acquired 170,000 - 0.11 0.05 0.16 View Detail
26-Dec-2018 ABDUL MANAF BIN MOHAMAD RADZI 21-Dec-2018 Acquired 50,000 0.320 0.11 0.00 0.11 View Detail
Trade this stock with T+7 trading account. Find out more.

  Be the first to like this.
donkeycharles what new business is that?
24/08/2020 10:34 AM
hksoon this counter myscm is a company doing biz for imported lorry and truck
24/08/2020 10:29 PM
Klseinspotlight Come on NOVA
Keep your ticket for higher
Let the price up
Let Nova limit up
25/08/2020 12:00 PM
HantuRaya2020 Hooorey! Ada dividen
01/09/2020 7:02 PM
shortinvestor77 Increased the amount of dividend from 1.1 cents a year to 1.43 cents in total this year. At least 30% of net profit is distributed according to its dividend policy.
02/09/2020 2:34 PM
HantuRaya2020 Wa.. mau upgrade da.. nasib wa ada beli
07/09/2020 6:47 PM
shortinvestor77 https://www.klsescreener.com/v2/announcements/view/3225063
07/09/2020 8:39 PM
shortinvestor77 proposed transfer of the listing of and quotation for the entire issued share capital of Nova from the ACE Market to the Main Market of Bursa Malaysia Securities Berhad ("Bursa Securities").
08/09/2020 9:24 AM
Johnmajor TP - RM 1.40. Accumulate while the price is still low.
17/09/2020 11:23 AM
hksoon Remind to @all : this counter been catecoried by Mr. Alfred Chan as one of the 6 pharmaceutical company in Malaysia. big + good + bright potential .
19/09/2020 3:07 PM
Abg_Tua limit up...potential..
20/09/2020 11:54 AM
jutawansenyap Eh ada Abg_Tua.Ingatkan dah pencen main saham. Kah kah kah
04/10/2020 2:44 AM
50Cents Post removed. Why?
08/10/2020 1:26 AM
Foker Shut up, you tiny tiny insignificant retailer cannot sway the share price la. Waste effort
08/10/2020 2:24 AM
HantuRaya2020 Wa mau tunggu wa punya dividen.
08/10/2020 12:14 PM
Johnmajor TP - RM 1.40
12/10/2020 3:25 PM
donkeycharles capital gain by december better be good
20/10/2020 2:49 PM
Johnmajor This company not ambitious enough.....
22/10/2020 11:30 AM
jaecyyy Hi all, im jaecy from uob kay hian. We are having promotions now with only 0.05% on brokerage charges for account opening. kindly contact me at 010-2680517 to know more details.
25/10/2020 3:00 PM
NPRA1985 Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December

“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”

07/11/2020 2:33 AM
HantuRaya2020 Agm ada org pi tak?
07/11/2020 12:10 PM
shortinvestor77 Online AGM lah. Semua boleh pergi, bang.
12/11/2020 8:36 PM
flyingtomoon2020 Nova gogogo
12/11/2020 8:39 PM
flyingtomoon2020 Post removed. Why?
12/11/2020 8:40 PM
NPRA1985 China's Sinopharm says data 'better than expected' from it's COVID vaccine trial

13/11/2020 5:10 PM
NPRA1985 China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

13/11/2020 9:54 PM
MS1979 Saturday 21 November 2020, 9.45pm, programme Investment Insider on Astro Awani will shows interview with Nova Wellness Group Bhd.
16/11/2020 1:19 PM
UnicornP Time to hit new high.
16/11/2020 6:35 PM
amateurJR Qtr result below expectation
16/11/2020 6:35 PM
shortinvestor77 Q1 result is very good as it is always seasonally weaker revenue quarter.
16/11/2020 7:07 PM
Principal im positive with the QR as there is strong growth of house brand and smart use of fund....but dont know tally with share price or not
16/11/2020 9:24 PM
shortinvestor77 Now revenue improved by 25% while net profit has improved by 44.6%. Where to find this kind of excellent performance amongst it's peers?
16/11/2020 10:54 PM
UnicornP Gonna be slow.
17/11/2020 8:57 AM
Johnmajor Nobody goreng that is why is slow to move up
17/11/2020 11:17 AM
donkeycharles anyone attended the agm? what are the takeaways?
20/11/2020 10:45 PM
NPRA1985 Post removed. Why?
23/11/2020 2:12 PM
donkeycharles when's the bread going to be sold?
25/11/2020 9:03 PM
oskchoon PM Muhyiddin announced free Covid-19 vaccine for all Malaysians...
27/11/2020 8:06 PM
donkeycharles when are they going to the main board?
04/12/2020 1:42 PM
donkeycharles easily RM2 stock, 2 more years maybe
06/12/2020 1:16 PM
NPRA1985 UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

09/12/2020 3:26 PM
NPRA1985 United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

09/12/2020 10:28 PM
NPRA1985 Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

11/12/2020 12:03 AM
donkeycharles dropping, shopping time
14/12/2020 8:25 PM
The1994Investor Nova - A supplement to consider for your portfolio

23/12/2020 10:35 PM
donkeycharles when are they going to main board?
29/12/2020 5:16 PM
HantuRaya2020 Baru je ade announcement
07/01/2021 6:25 PM
Yiingb Nova flying up soooooooon
08/01/2021 11:19 AM
donkeycharles how come?
11/01/2021 11:27 PM
donkeycharles still not transferred yet
14/01/2021 5:48 PM

I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program

457  490  616  543 

Top 10 Active Counters
 PRG 0.285+0.055 
 PNEPCB 0.42-0.08 
 XOX 0.105-0.005 
 AT 0.185+0.01 
 SEALINK 0.18+0.015 
 GPA 0.125+0.015 
 IRIS 0.405-0.01 
 JCY 0.515-0.07 
 MTRONIC 0.105+0.005 
 ASIAPLY 0.30+0.03 


1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!


1. Evidence that prove JP Morgan's Jeffrey Ng analyst report on Glove is irresponsible and materially full with unreliable data GillianTan Reviews
2. UNISEM (5005) - Super Powerful Technology Counter Bursa Malaysia Free Trading Education
3. 1% left of Topglove shares to be shorted by JP Morgan and their foreign associates. Don't let foreign investors fool you to sell GillianTan Reviews
4. Gloves - Some Significant Problems with JP Morgan's Report Trying to Make Sense Bursa Investments
5. AT Glove (0072) - Second glove factory (Step 5) Rubber Glove companies till year 2023
6. Daily technical highlights – (OCK, TGUAN) Kenanga Research & Investment
7. Gloves Market Revenue - CAGR 13% during period 2021-2026 Rubber Glove companies till year 2023
8. Thong Guan Industries Bhd - Beaten Down Too Much Kenanga Research & Investment